SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: Miljenko Zuanic who wrote (2797)11/19/2019 5:22:20 PM
From: Miljenko Zuanic  Respond to of 3557
 
CD28-superagonist (TGN1412), Tegenero disaster from 2006!

what went wrong and ,,,,,how to fix it????
ncbi.nlm.nih.gov



To: Miljenko Zuanic who wrote (2797)11/23/2019 12:13:13 PM
From: Felix B  Read Replies (1) | Respond to of 3557
 
I think after Q1 or Q2 of 2020 will be key to see how much NVS has penetrated Eylea sales in addition to the costim readouts. 2020 could be a big inflection point for REGN